SCHEMBL111101

SCHEMBL111101

COC(=O)[C@@H](N)CCS

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL111100 1.00
SCHEMBL111102 1.00
Hydrochloric Acid SCHEMBL29213060 0.98 ANPEP (0.38)
Hydrochloric Acid SCHEMBL29213058 0.98 ANPEP (0.38)
SCHEMBL16657543 0.87 FOLH1 (0.39)
SCHEMBL11776470 0.85 SMN1; SMN2 (0.42)
SCHEMBL6776048 0.84 ZDHHC7 (0.42)
SCHEMBL18870138 0.83 ANPEP (0.36)
Mecysteine SCHEMBL21034 0.81
Mecysteine SCHEMBL94255 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 143 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113214043-B Method for efficiently preparing deuterated methyl iodide and application thereof 云南民族大学 2024-02-06 CN claimed
CN-114907546-B Multifunctional polyurea acid ester derivative and preparation method and application thereof 四川大学 2023-06-02 CN claimed
CN-114907546-A Multifunctional polyurea acid ester derivative and preparation method and application thereof 四川大学 2022-08-16 CN claimed
CN-114716635-A Multifunctional polyurea-amino acid derivative and preparation method and application thereof 四川大学 2022-07-08 CN claimed
EP-2309983-B1 PHARMACEUTICAL FORM COMPRISING TETRAHYDROBIOPTERIN ORPHA SWISS GMBH (CH) 2019-04-24 EP claimed
CN-103122365-A Target gene Rv3290c for screening antituberculous inhibitor and application UNIV HUAZHONG AGRICULTURAL 2013-05-29 CN claimed
CN-102802605-A Stable lipid formulations of apoptosis promoters ABBOTT LAB 2012-11-28 CN claimed
EP-2424499-A1 STABILIZED LIPID FORMULATION OF APOPTOSIS PROMOTER Abbott Laboratories (US) 2012-03-07 EP claimed
US-20110144117-A1 Pharmaceutical Dosage Form Containing Tetrahydrobiopterin ORPHA SWISS GMBH (CH) 2011-06-16 US claimed
EP-2309983-A2 PHARMACEUTICAL FORM COMPRISING TETRAHYDROBIOPTERIN Orpha Swiss GmbH (CH) 2011-04-20 EP claimed
US-20100278905-A1 STABILIZED LIPID FORMULATION OF APOPTOSIS PROMOTER ABBVIE INC. 2010-11-04 US claimed
WO-2010127193-A1 STABILIZED LIPID FORMULATION OF APOPTOSIS PROMOTER ABBOTT LABORATORIES (US) 2010-11-04 WO claimed
WO-2010017570-A2 PHARMACEUTICAL FORM COMPRISING TETRAHYDROBIOPTERIN ORPHA SWISS GMBH (CH) 2010-02-18 WO claimed
WO-2009049746-A2 HAIR-TREATMENT COMPOSITION BASED ON SULPHUR-CONTAINING ANIONOGENIC POLYMERS GREEN RIVER POLYMERS FORSCHUNGS- UND ENTWICKLUNGS GMBH (AT) 2009-04-23 WO claimed
US-20250057957-A1 SPIROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATION C4 THERAPEUTICS, INC. (US) 2025-02-20 US disclosed
EP-4483875-A2 SPIROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATION C4 Therapeutics, Inc. (US) 2025-01-01 EP disclosed
EP-3454862-B1 SPIROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATION C4 THERAPEUTICS INC (US) 2024-09-11 EP disclosed
US-5720944-A POLYGLYCOL MONOTHIO(GLYCOLATE OR LACTATE) AS REDUCING AGENTS KAO CORPORATION (JP) 1998-02-24 US disclosed
EP-0734715-A2 1,3-Butanediol thioglycolate isomer mixture and permanent waving composition comprising same Kao Corporation (JP) 1996-10-02 EP disclosed
EP-0734716-A2 Composition for permanent waving of human hair Kao Corporation (JP) 1996-10-02 EP disclosed